Atypical lipomatous tumor

Molecular characterization

Gianluigi Arrigoni, Claudio Doglioni

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Purpose of review: Atypical lipomatous tumors/well-differentiated liposarcomas (ALT/WDLs) are one of the more frequent mesenchymal neoplasms and are characterized by specific chromosome aberrations: supernumerary chromosome or giant marker chromosome or both. Extra copies of known oncogenes such as MDM2, CDK4, SAS, HMGA2 and others are present in this abnormal genetic material. Recent findings: In the past few years, several papers have further dissected the genetic alterations present in these tumors, allowing the identification of new potential oncogenes. Summary: ALT/WDLs represent therefore an interesting model for assessing the potential role of these oncogenes, not only in the pathogenesis, but also as a therapeutic target.

Original languageEnglish
Pages (from-to)355-358
Number of pages4
JournalCurrent Opinion in Oncology
Volume16
Issue number4
DOIs
Publication statusPublished - Jul 2004

Fingerprint

Oncogenes
Liposarcoma
Neoplasms
Genetic Markers
Chromosome Aberrations
Chromosomes
Genes
Therapeutics

Keywords

  • Atypical lipomatous tumor
  • Genetic alterations
  • MDM2
  • Well-differentiated liposarcoma

ASJC Scopus subject areas

  • Cancer Research

Cite this

Atypical lipomatous tumor : Molecular characterization. / Arrigoni, Gianluigi; Doglioni, Claudio.

In: Current Opinion in Oncology, Vol. 16, No. 4, 07.2004, p. 355-358.

Research output: Contribution to journalArticle

@article{3de142fe201342ce95f3b1a7bb8d10e3,
title = "Atypical lipomatous tumor: Molecular characterization",
abstract = "Purpose of review: Atypical lipomatous tumors/well-differentiated liposarcomas (ALT/WDLs) are one of the more frequent mesenchymal neoplasms and are characterized by specific chromosome aberrations: supernumerary chromosome or giant marker chromosome or both. Extra copies of known oncogenes such as MDM2, CDK4, SAS, HMGA2 and others are present in this abnormal genetic material. Recent findings: In the past few years, several papers have further dissected the genetic alterations present in these tumors, allowing the identification of new potential oncogenes. Summary: ALT/WDLs represent therefore an interesting model for assessing the potential role of these oncogenes, not only in the pathogenesis, but also as a therapeutic target.",
keywords = "Atypical lipomatous tumor, Genetic alterations, MDM2, Well-differentiated liposarcoma",
author = "Gianluigi Arrigoni and Claudio Doglioni",
year = "2004",
month = "7",
doi = "10.1097/01.cco.0000127878.85125.53",
language = "English",
volume = "16",
pages = "355--358",
journal = "Current Opinion in Oncology",
issn = "1040-8746",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Atypical lipomatous tumor

T2 - Molecular characterization

AU - Arrigoni, Gianluigi

AU - Doglioni, Claudio

PY - 2004/7

Y1 - 2004/7

N2 - Purpose of review: Atypical lipomatous tumors/well-differentiated liposarcomas (ALT/WDLs) are one of the more frequent mesenchymal neoplasms and are characterized by specific chromosome aberrations: supernumerary chromosome or giant marker chromosome or both. Extra copies of known oncogenes such as MDM2, CDK4, SAS, HMGA2 and others are present in this abnormal genetic material. Recent findings: In the past few years, several papers have further dissected the genetic alterations present in these tumors, allowing the identification of new potential oncogenes. Summary: ALT/WDLs represent therefore an interesting model for assessing the potential role of these oncogenes, not only in the pathogenesis, but also as a therapeutic target.

AB - Purpose of review: Atypical lipomatous tumors/well-differentiated liposarcomas (ALT/WDLs) are one of the more frequent mesenchymal neoplasms and are characterized by specific chromosome aberrations: supernumerary chromosome or giant marker chromosome or both. Extra copies of known oncogenes such as MDM2, CDK4, SAS, HMGA2 and others are present in this abnormal genetic material. Recent findings: In the past few years, several papers have further dissected the genetic alterations present in these tumors, allowing the identification of new potential oncogenes. Summary: ALT/WDLs represent therefore an interesting model for assessing the potential role of these oncogenes, not only in the pathogenesis, but also as a therapeutic target.

KW - Atypical lipomatous tumor

KW - Genetic alterations

KW - MDM2

KW - Well-differentiated liposarcoma

UR - http://www.scopus.com/inward/record.url?scp=3042806948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042806948&partnerID=8YFLogxK

U2 - 10.1097/01.cco.0000127878.85125.53

DO - 10.1097/01.cco.0000127878.85125.53

M3 - Article

VL - 16

SP - 355

EP - 358

JO - Current Opinion in Oncology

JF - Current Opinion in Oncology

SN - 1040-8746

IS - 4

ER -